# RELMADA THERAPEUTICS, INC.: Form D filings

RELMADA THERAPEUTICS, INC., a biotechnology company in New York, NY, filed 10 Form D notices with the SEC between 2014 and 2019. The latest, on October 8, 2019, reports $825,750 sold of a $825,750 offering to 7 investors.

Find out what RELMADA THERAPEUTICS, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20RELMADA%20THERAPEUTICS%2C%20INC.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=RELMADA%20THERAPEUTICS%2C%20INC.&page=%2Fdata%2Fform-d%2Fcompany%2Frelmada-therapeutics-inc-1553643)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20RELMADA%20THERAPEUTICS%2C%20INC.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=RELMADA%20THERAPEUTICS%2C%20INC.&page=%2Fdata%2Fform-d%2Fcompany%2Frelmada-therapeutics-inc-1553643)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in New York](https://specstream.ai/data/form-d/state/new-york): 4,357 rows, by operating companies, filed since November 1, 2024, $123.57, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/new-york
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 880 3RD AVENUE, 12TH FLOOR, New York, NY, 10022
- Phone: (646) 876-3459
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Nevada
- Revenue range: No Revenues
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1553643

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Oct 8, 2019 | New notice | $825,750 | $825,750 | $0 | 7 | Sep 23, 2019 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1553643/000121390019019994/0001213900-19-019994-index.htm) |
| Jul 10, 2019 | Amendment | $10,000,000 | $8,432,437 | $1,567,563 | 116 | Jun 14, 2019 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1553643/000121390019012436/0001213900-19-012436-index.htm) |
| Jun 27, 2019 | New notice | $10,000,000 | $8,002,248 | $1,997,752 | 108 | Jun 14, 2019 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1553643/000121390019011648/0001213900-19-011648-index.htm) |
| May 16, 2019 | New notice | $10,000,000 | $3,414,505 | $6,585,495 | 43 | May 14, 2019 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1553643/000121390019009006/0001213900-19-009006-index.htm) |
| Dec 10, 2018 | Amendment | $10,000,000 | $5,834,407 | $4,165,593 | 66 | Oct 12, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1553643/000121390018017157/0001213900-18-017157-index.htm) |
| Nov 13, 2018 | Amendment | $10,000,000 | $4,629,507 | $5,370,493 | 55 | Oct 12, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1553643/000121390018015444/0001213900-18-015444-index.htm) |
| Oct 22, 2018 | New notice | $10,000,000 | $3,279,998 | $6,720,002 | 30 | Oct 12, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1553643/000121390018014204/0001213900-18-014204-index.htm) |
| Oct 6, 2017 | New notice | $6,890,000 | $6,890,000 | $0 | 65 | Sep 28, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1553643/000121390017010345/0001213900-17-010345-index.htm) |
| Jun 19, 2014 | New notice | $10,694,588 | $10,694,588 | $0 | 236 | Jun 10, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1553643/000121390014004304/0001213900-14-004304-index.htm) |
| Jun 4, 2014 | New notice | $0 | $0 | $0 | 382 | May 20, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1553643/000121390014003956/0001213900-14-003956-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Maged Shenouda | Director |  |
| Ottavio Vitolo | Executive Officer |  |
| Paul Kelly | Director |  |
| Charles Casamento | Director |  |
| Chuck Ence | Executive Officer |  |
| Sergio Traversa | Executive Officer, Director |  |

## Other biotechnology companies in New York that filed recently

- [Swep Bio, Inc.](https://specstream.ai/data/form-d/company/swep-bio-inc-2159106) $2.5 million · Oct 29, 2026
- [Hypercell Technologies Inc.](https://specstream.ai/data/form-d/company/hypercell-technologies-inc-1882357) $3 million · Oct 14, 2026
- [CAD Therapeutics, Inc.](https://specstream.ai/data/form-d/company/cad-therapeutics-inc-2157566) $4 million · Oct 2, 2026
- [Vicora, Inc.](https://specstream.ai/data/form-d/company/vicora-inc-2091847) $2.3 million · Sep 18, 2026
- [GevRx Nutraceuticals, Inc.](https://specstream.ai/data/form-d/company/gevrx-nutraceuticals-inc-2156105) $300,000 · Sep 18, 2026
- [Episteme Prognostics, Inc.](https://specstream.ai/data/form-d/company/episteme-prognostics-inc-1902402) $5.1 million · Sep 4, 2026

[Every Form D from the week of Oct 7, 2019](https://specstream.ai/data/form-d/week/2019-10-07) · [All recent filings in New York](https://specstream.ai/data/form-d/state/new-york) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what RELMADA THERAPEUTICS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).